ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1005

The Identification of Pathway Markers in Behcet’s Disease Using Genomewide Association Data From Two Different Populations

Burcu Bakir-Gungor1, Elaine Remmers2, Daniel L. Kastner2, Akira Meguro3, Nobuhisa Mizuki4, Ahmet Gul5 and Osman Ugur Sezerman6, 1Department of Genetics and Bioinformatics, Faculty of Arts and Sciences, Bahcesehir University, Istanbul, Turkey, 2Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 3Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 4Yokohama City University Graduate School of Medicine, Yokohama, Japan, 5Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 6Biological Sciences and Bioengineering, Faculty of Engineering and Natural Sciences, Sabancı University, Istanbul, Turkey

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, genomics and inflammation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Behcet’s disease (BD) is a multi-system inflammatory disease, characterized by recurrent exacerbations affecting several organs including orogenital mucosa, eyes and skin. Two recent genome-wide association study (GWAS) of BD in Turkish and Japanese populations both confirmed the strong association of MHC Class I region and identified two non-HLA common genetic variations with a mild effect on BD. In complex diseases such as BD, multiple factors [e.g. single nucleotide polymorphisms (SNPs), miRNAs, metabolic and epigenetic factors] may target different sets of genes in the same pathway crippling its function and thus causing the disease development. In this regard, we hypothesized that the pathways critical to the mechanisms underlying BD will be conserved within and across populations.  

Methods: To identify these disease-associated pathways, we previously developed a novel methodology that combines nominally significant evidence of genetic association with current knowledge of biochemical pathways, protein-protein interaction networks, and functional information of selected SNPs. Using this methodology, we herein searched for the disease related pathways on two BD GWAS in Turkish and Japanese case–control cohorts by using the list of SNPs providing a P value <0,05. 

Results: Even though there were a few significantly conserved SNPs/genes within and between populations, five of the top ten affected pathways were found to be significant in both populations. The probability of random occurrence of such an event is 5.13E-36. These shared pathways were Notch signaling pathway, focal adhesion, Jak-STAT signaling pathway, long-term potentiation and pathways in cancer. Considering some differences in the clinical manifestations such as more frequent involvement of major vessels in Turkish patients, we observed some correlating rankings in the pathways. The complement and coagulation cascades pathway was identified in 5th and 33rd rankings with P=2.47E-20, P=2.6E-12 in Turkish and Japanese populations, respectively.  

Conclusion: By applying our method on two BD GWAS dataset, here we have shown that while the total number of genome-wide significant genetic associations is limited, identification of the shared pathways between the Turkish and the Japanese populations may help further explaining the general mechanisms of BD pathogenesis. Even though each individual has a unique combination of factors involved in disease development mechanism, most of the targeted pathways that need to be altered by these factors are expected to be conserved. The pathways that are identified by population specific GWAS need to be examined to gain a more comprehensive understanding of BD pathogenesis and their potential to be used as biomarkers and/or drug targets.


Disclosure:

B. Bakir-Gungor,
None;

E. Remmers,
None;

D. L. Kastner,
None;

A. Meguro,
None;

N. Mizuki,
None;

A. Gul,
None;

O. U. Sezerman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-identification-of-pathway-markers-in-behcets-disease-using-genomewide-association-data-from-two-different-populations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology